208 related articles for article (PubMed ID: 32115575)
1. The lysine methyltransferase SMYD2 is required for normal lymphocyte development and survival of hematopoietic leukemias.
Brown MA; Edwards MA; Alshiraihi I; Geng H; Dekker JD; Tucker HO
Genes Immun; 2020 Feb; 21(2):119-130. PubMed ID: 32115575
[TBL] [Abstract][Full Text] [Related]
2. The Lysine Methyltransferase SMYD2 Is Required for Definite Hematopoietic Stem Cell Production in the Mouse Embryo.
Edwards MA; Brown MA; Alshiraihi I; Jarrell DK; Tucker HO
Vet Sci; 2020 Jul; 7(3):. PubMed ID: 32722433
[TBL] [Abstract][Full Text] [Related]
3. Smyd2 is a Myc-regulated gene critical for MLL-AF9 induced leukemogenesis.
Bagislar S; Sabò A; Kress TR; Doni M; Nicoli P; Campaner S; Amati B
Oncotarget; 2016 Oct; 7(41):66398-66415. PubMed ID: 27655694
[TBL] [Abstract][Full Text] [Related]
4. The lysine methyltransferases SET and MYND domain containing 2 (Smyd2) and Enhancer of Zeste 2 (Ezh2) co-regulate osteoblast proliferation and mineralization.
Dashti P; van de Peppel J; Thaler R; Paradise CR; Stein GS; Montecino MA; van Leeuwen JPTM; van der Eerden BJ; Dudakovic A; van Wijnen AJ
Gene; 2023 Jan; 851():146928. PubMed ID: 36191822
[TBL] [Abstract][Full Text] [Related]
5. Cardiac deletion of Smyd2 is dispensable for mouse heart development.
Diehl F; Brown MA; van Amerongen MJ; Novoyatleva T; Wietelmann A; Harriss J; Ferrazzi F; Böttger T; Harvey RP; Tucker PW; Engel FB
PLoS One; 2010 Mar; 5(3):e9748. PubMed ID: 20305823
[TBL] [Abstract][Full Text] [Related]
6. The histone methyltransferase Smyd2 is a negative regulator of macrophage activation by suppressing interleukin 6 (IL-6) and tumor necrosis factor α (TNF-α) production.
Xu G; Liu G; Xiong S; Liu H; Chen X; Zheng B
J Biol Chem; 2015 Feb; 290(9):5414-23. PubMed ID: 25583990
[TBL] [Abstract][Full Text] [Related]
7. SMYD2 Drives Mesendodermal Differentiation of Human Embryonic Stem Cells Through Mediating the Transcriptional Activation of Key Mesendodermal Genes.
Bai HJ; Zhang P; Ma L; Liang H; Wei G; Yang HT
Stem Cells; 2019 Nov; 37(11):1401-1415. PubMed ID: 31348575
[TBL] [Abstract][Full Text] [Related]
8. Characterizing the Role of SMYD2 in Mammalian Embryogenesis-Future Directions.
Jarrell DK; Hassell KN; Crans DC; Lanning S; Brown MA
Vet Sci; 2020 May; 7(2):. PubMed ID: 32408548
[TBL] [Abstract][Full Text] [Related]
9. Lysine methyltransferase Smyd2 regulates Hsp90-mediated protection of the sarcomeric titin springs and cardiac function.
Voelkel T; Andresen C; Unger A; Just S; Rottbauer W; Linke WA
Biochim Biophys Acta; 2013 Apr; 1833(4):812-22. PubMed ID: 23047121
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of Smyd2: a split SET/MYND domain-containing histone H3 lysine 36-specific methyltransferase that interacts with the Sin3 histone deacetylase complex.
Brown MA; Sims RJ; Gottlieb PD; Tucker PW
Mol Cancer; 2006 Jun; 5():26. PubMed ID: 16805913
[TBL] [Abstract][Full Text] [Related]
11. Proteomic analyses of the SMYD family interactomes identify HSP90 as a novel target for SMYD2.
Abu-Farha M; Lanouette S; Elisma F; Tremblay V; Butson J; Figeys D; Couture JF
J Mol Cell Biol; 2011 Oct; 3(5):301-8. PubMed ID: 22028380
[TBL] [Abstract][Full Text] [Related]
12. Lysine methyltransferase SMYD2 promotes triple negative breast cancer progression.
Li LX; Zhou JX; Calvet JP; Godwin AK; Jensen RA; Li X
Cell Death Dis; 2018 Feb; 9(3):326. PubMed ID: 29487338
[TBL] [Abstract][Full Text] [Related]
13. Lysine methyltransferase SMYD2 promotes cyst growth in autosomal dominant polycystic kidney disease.
Li LX; Fan LX; Zhou JX; Grantham JJ; Calvet JP; Sage J; Li X
J Clin Invest; 2017 Jun; 127(7):2751-2764. PubMed ID: 28604386
[TBL] [Abstract][Full Text] [Related]
14. The tale of two domains: proteomics and genomics analysis of SMYD2, a new histone methyltransferase.
Abu-Farha M; Lambert JP; Al-Madhoun AS; Elisma F; Skerjanc IS; Figeys D
Mol Cell Proteomics; 2008 Mar; 7(3):560-72. PubMed ID: 18065756
[TBL] [Abstract][Full Text] [Related]
15. Structural insights into estrogen receptor α methylation by histone methyltransferase SMYD2, a cellular event implicated in estrogen signaling regulation.
Jiang Y; Trescott L; Holcomb J; Zhang X; Brunzelle J; Sirinupong N; Shi X; Yang Z
J Mol Biol; 2014 Oct; 426(20):3413-25. PubMed ID: 24594358
[TBL] [Abstract][Full Text] [Related]
16. Coordination of stress signals by the lysine methyltransferase SMYD2 promotes pancreatic cancer.
Reynoird N; Mazur PK; Stellfeld T; Flores NM; Lofgren SM; Carlson SM; Brambilla E; Hainaut P; Kaznowska EB; Arrowsmith CH; Khatri P; Stresemann C; Gozani O; Sage J
Genes Dev; 2016 Apr; 30(7):772-85. PubMed ID: 26988419
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of SET and MYND Domain-Containing Protein 2 (SMYD2) Is Associated with Tumor Progression and Poor Prognosis in Patients with Papillary Thyroid Carcinoma.
Xu W; Chen F; Fei X; Yang X; Lu X
Med Sci Monit; 2018 Oct; 24():7357-7365. PubMed ID: 30319138
[TBL] [Abstract][Full Text] [Related]
18. SMYD2-Mediated Histone Methylation Contributes to HIV-1 Latency.
Boehm D; Jeng M; Camus G; Gramatica A; Schwarzer R; Johnson JR; Hull PA; Montano M; Sakane N; Pagans S; Godin R; Deeks SG; Krogan NJ; Greene WC; Ott M
Cell Host Microbe; 2017 May; 21(5):569-579.e6. PubMed ID: 28494238
[TBL] [Abstract][Full Text] [Related]
19. Regulation of EZH2 by SMYD2-Mediated Lysine Methylation Is Implicated in Tumorigenesis.
Zeng Y; Qiu R; Yang Y; Gao T; Zheng Y; Huang W; Gao J; Zhang K; Liu R; Wang S; Hou Y; Yu W; Leng S; Feng D; Liu W; Zhang X; Wang Y
Cell Rep; 2019 Nov; 29(6):1482-1498.e4. PubMed ID: 31693890
[TBL] [Abstract][Full Text] [Related]
20. Structure of human lysine methyltransferase Smyd2 reveals insights into the substrate divergence in Smyd proteins.
Xu S; Zhong C; Zhang T; Ding J
J Mol Cell Biol; 2011 Oct; 3(5):293-300. PubMed ID: 21724641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]